Phase 1 Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Adolescent
Clinical trial NCT03806699 · UNKNOWN
Trial details
- NCT number
- NCT03806699
- Sponsor
- Quratis Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-02
- Primary completion
- 2020-09-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.